Skip to main content
SGP
NASDAQ Industrial Applications And Services

10% Owner Mohamad Makhzoumi Buys $15M in SpyGlass Pharma Stock Post-IPO

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$26.18
Mkt Cap
$835.434M
52W Low
$24.71
52W High
$28.929
52W Position info
5.9% above low
Off High info
9.5% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

SGP is trading near its 52-week low of $24.71 (5.9% above the low).

Summary

Mohamad Makhzoumi, a 10% owner affiliated with New Enterprise Associates, made a substantial $15 million open market purchase of SpyGlass Pharma common stock at the IPO price, alongside the automatic conversion of $169 million in preferred shares.


Key Events · Ownership and Investor Activity · SGP

  • Significant Open Market Purchase

    Mohamad Makhzoumi, a 10% owner, purchased $15 million worth of common stock on the open market.

  • Purchase at IPO Price

    The purchase was made at the IPO price of $16.00 per share on February 9, 2026, the same day the IPO closed.

  • Large Preferred Stock Conversion

    Additionally, approximately $169 million in preferred stock automatically converted to common stock as part of the IPO, solidifying a substantial institutional holding.

  • Part of Broader Insider Accumulation

    This transaction follows a series of significant insider purchases by other directors and 10% owners post-IPO, indicating a strong cluster buying signal.


Analysis · SGP · Industrial Applications And Services

This filing highlights a significant vote of confidence from a major institutional investor, Mohamad Makhzoumi, a 10% owner associated with New Enterprise Associates. The $15 million open market purchase, executed at the IPO price of $16.00 per share, represents a substantial investment following the company's recent public debut. This discretionary purchase, combined with the automatic conversion of approximately $169 million in preferred stock to common stock, solidifies a massive stake in SpyGlass Pharma. This transaction is part of a broader pattern of strong insider accumulation post-IPO, with multiple directors also making significant purchases, signaling robust internal conviction in the company's future prospects.

How filings like this one have moved

In the 30 days to Oct 3, 2026, 40.9% of the 320 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SGP was trading at $26.18 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $835.4M. The 52-week trading range was $24.71 to $28.93. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SGP - Latest Insights

SGP
Oct 01, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $26.00
Real-time Price: $24.92 info
Change: -$1.08 (-4%) info
Market Cap: $833.524M info
SGP
Aug 06, 2026, 4:37 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $24.38
Real-time Price: $24.92 info
Change: +$0.540 (+2%) info
Market Cap: $833.524M info
SGP
May 14, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $24.27
Real-time Price: $24.92 info
Change: +$0.650 (+3%) info
Market Cap: $833.524M info
SGP
May 14, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $24.27
Real-time Price: $24.92 info
Change: +$0.650 (+3%) info
Market Cap: $833.524M info
SGP
May 14, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $24.27
Real-time Price: $24.92 info
Change: +$0.650 (+3%) info
Market Cap: $833.524M info